Want to see GB:50GP full AI Analyst Report?
Croda International (50GP) AI Stock Analysis
Top Page
Croda International
(LSE:50GP)
The score is anchored by mixed fundamentals: a relatively stable balance sheet and improving recent free cash flow are offset by a weaker multi-year net income trend. The earnings call adds support due to reiterated guidance, improving margins/EPS, and visible cost savings, but technicals are stretched (overbought signals) and valuation is a headwind given the high P/E and an unreliable dividend yield figure in the provided data.
Croda International (50GP) vs. iShares MSCI United Kingdom ETF (EWC)
- Market Cap
- GBP 50.83M
- Dividend Yield
- 766.23%
- Average Volume (3M)
- 25.76K
- Price to Earnings (P/E)
- 64.4
- Beta (1Y)
- 0.11
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- UK
- Employees
- 5,954
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Chemicals - Specialty
Croda International Business Overview & Revenue Model
Company Description
Croda International Plc is a global enterprise specializing in the development, manufacturing, and distribution of high-performance chemicals, with its market reach spanning Europe, the Middle East, Africa, North America, Asia, and Latin America. The...
How the Company Makes Money
Croda makes money primarily by selling specialty chemical ingredients and ingredient technologies to business customers (B2B) across consumer care and industrial markets. Its revenue model is largely product sales, where customers pay per unit/volume...
Croda International Earnings Call Summary
The call conveyed a broadly positive performance: underlying sales, EPS and margins improved with clear signs of momentum in innovation-led growth (notably Beauty Actives and Pharma Ingredients), transformation savings are materializing, and strategic capacity expansions in Asia support future growth. Challenges remain—Pharma Solutions timing, Crop Protection weakness, regional/segment softness (North America mass market), working capital outflows and one-off OpEx inflation—but these are presented as manageable or phased rather than structural. Management reiterated full-year guidance (organic sales growth 3–6%) and the 3-year targets through 2028, signaling confidence in execution.
Q2-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Management reiterated unchanged full‑year guidance, forecasting organic sales growth of 3–6% and a further increase in adjusted operating margin, with adjusted operating profit expectations unchanged and FX sensitivities provided; they also said the Q2 exit rate gives confidence in sequential margin improvement in H2 and that the group remains on track for its 3‑year/2028 financial framework. In support, H1 sales were £881m (+5%) with NPP +7%, volumes +1% and price/mix +4%; adjusted operating profit was £156m (+7%) and margin rose to 17.7% (from 17.2%), EPS 78p (+9%), EBITDA £208m, free cash flow £38m (vs £28m), net debt £578m (leverage 1.4x) and an interim dividend of 48p. Management said transformation delivered £18m of H1 savings (cumulative £46m toward a £100m target), CapEx fell to £43m, and a working‑capital program aims for ~£50m of structural savings by 2028 to offset typical annual WC funding of £20–30m.
Croda International Financial Statement Overview
Summary
Financials are mixed: the balance sheet is relatively solid (manageable leverage historically, though debt rose and equity fell in 2025), and cash generation is consistently positive with a strong free-cash-flow rebound in 2025. The main drag is profitability trajectory—net income has stepped down materially from 2022 through 2025 despite modest revenue recovery, indicating weaker earnings power.
Income Statement
58NeutralBalance Sheet
74PositiveCash Flow
67Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.72B | 1.70B | 1.63B | 1.69B | 2.09B | 1.89B |
| Gross Profit | 615.90M | 608.70M | 733.90M | 730.00M | 864.90M | 825.60M |
| EBITDA | 390.10M | 380.70M | 374.50M | 388.50M | 924.80M | 549.40M |
| Net Income | 79.50M | 62.00M | 158.50M | 171.00M | 649.30M | 320.80M |
Balance Sheet | ||||||
| Total Assets | 3.53B | 3.41B | 3.51B | 3.58B | 3.61B | 3.29B |
| Cash, Cash Equivalents and Short-Term Investments | 205.30M | 172.80M | 166.80M | 172.50M | 320.60M | 112.80M |
| Total Debt | 783.20M | 696.60M | 699.10M | 710.10M | 615.80M | 936.00M |
| Total Liabilities | 1.34B | 1.21B | 1.21B | 1.21B | 1.18B | 1.53B |
| Stockholders Equity | 2.17B | 2.19B | 2.28B | 2.35B | 2.42B | 1.75B |
Cash Flow | ||||||
| Free Cash Flow | 187.80M | 171.80M | 137.60M | 156.80M | 160.90M | 190.50M |
| Operating Cash Flow | 283.40M | 289.50M | 319.40M | 337.50M | 313.30M | 349.20M |
| Investing Cash Flow | -93.00M | -109.80M | -139.10M | -409.80M | 418.10M | -218.40M |
| Financing Cash Flow | -175.90M | -152.60M | -182.60M | -52.40M | -550.90M | -111.90M |
Croda International Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:50GP, the sentiment is Neutral. The current price of 77.00 is above the 20-day moving average (MA) of 76.40, above the 50-day MA of 76.14, and below the 200-day MA of 78.11, indicating a neutral trend. The MACD of 0.27 indicates Negative momentum. The RSI at 80.89 is Negative, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GB:50GP.
Croda International Peers Comparison
Overall Rating
GB:ELM73Outperform- GB:50GP63Neutral
GB:VCT59Neutral
GB:SYNT57Neutral
GB:JMAT51Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| GB:ELM | 73Outperform | GBP 1.06B | 19.35 | 11.29% | 1.78% | -11.73% | ― |
| GB:50GP | 63Neutral | GBP 5.09B | 64.43 | 3.65% | 766.23% | ― | ― |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| GB:VCT | 59Neutral | GBP 786.60M | -39.26 | -4.95% | 2.97% | -1.24% | -166.15% |
| GB:SYNT | 57Neutral | GBP 181.98M | -1.52 | -13.27% | ― | -4.98% | -43.98% |
| GB:JMAT | 51Neutral | GBP 2.97B | -41.89 | -4.66% | 4.49% | 7.70% | -128.58% |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| GB:50GP | Croda International (50GP) | 77.00 | 4.77 | 6.61% | |
| GB:ELM | Elementis plc | 187.20 | 25.84 | 16.01% | |
| GB:JMAT | Johnson Matthey (Uk) | 2388.00 | 270.54 | 12.78% | |
| GB:SYNT | Synthomer plc | 111.00 | 58.70 | 112.24% | |
| GB:VCT | Victrex plc | 903.00 | 319.23 | 54.68% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 28, 2026